Back to Journals Drug Design, Development and Therapy Volume 19 A Comprehensive Review on the Pharmacokinetics and DrugDrug Interactions of Approved GLP-1 Receptor Agonists and a Dual GLP-1/GIP Receptor Agonist Authors Min JS, Jo SJ, Lee S, Kim DY, Kim DH, Lee CB , Bae SK Received 17 November 2024 Accepted for publication 14 April 2025 Published 30 April 2025 Volume 2025:19 Pages 35093537 DOI Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 2 Editor who approved publication: Prof
This is useful because extragastric impaired motility occurs in more than 40% of those with suspected gastroparesis, and gastrointestinal symptoms do not correlate well with the gastrointestinal segment affected
They also discussed evidence of its clinical effectiveness in treating eating disorders, neurodegenerative diseases, substance use disorders, and pain [7]
When evaluating a provider, consider asking: What is your training or experience with peptides